Structure Therapeutics Rings the Opening Bell

About This Event

Structure Therapeutics (Nasdaq: GPCR) visits the Nasdaq MarketSite in Times Square. Structure Therapeutics is a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative oral treatments for chronic metabolic and pulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the company has established a scientifically driven GPCR-targeted pipeline, featuring an oral GLP-1 receptor agonist designed to replace injectable biologic and peptide therapies and be accessible to more patients around the world. In honor of the occasion, Raymond Stevens, CEO, rings the Opening Bell.